Fubao Wang

Fubao Wang

Company: Prime Medicine

Job title: Senior Vice President, Head of Regulatory Affairs

Seminars:

Chair’s Closing Remarks 3:15 pm

Read more

day: Conference Day Two

Panel Discussion: Exploring Recent Guidance on Platform Technologies to Clarify Frameworks for Approaches Used Across the Cell & Gene Field 2:00 pm

Considering what should be included on a platform basis or potentially excluded from a CMC, non-clinical, or procedural basis Enhancing the developmental process and efficiency by understanding the versatility of platform technologies and clarifying guidance on approaches Leveraging standardized systems to expedite the production of several cell and gene therapy productsRead more

day: Conference Day Two

Chair’s Opening Remarks 8:50 am

Read more

day: Conference Day Two

Panel Discussion: Navigating Various Assigned Designations like Orphan, Prime, & More to Clarify Criteria & Distinctions 12:00 pm

Breaking down criteria for different platform designations to streamline decisions on the most suitable designation for your therapy Emphasizing specific advantages of certain designation allocations to rationalize plans for application Tackling challenges in applying for platform designations to streamline the application and approval processRead more

day: Conference Day One

Industry Leaders Fireside Chat: Insights from Leading Experts on Overcoming Current & Future Regulatory Challenges in the Cell & Gene Therapy Field 9:00 am

What are the key obstacles challenging the cell and gene space now? Where will the cell and gene space be in 5 years, and how will this impact the regulation of these treatments? How can service providers assist biopharma in paving the way forward?Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.